| Record ID | marc_records_scriblio_net/part27.dat:137093496:1216 |
| Source | Scriblio |
| Download Link | /show-records/marc_records_scriblio_net/part27.dat:137093496:1216?format=raw |
LEADER: 01216cam 2200301 a 4500
001 98139493
003 DLC
005 20000614081326.0
008 980225s1998 enka 101 0 eng d
010 $a 98139493
020 $a0792387295 :$c£50.00
035 $a(OCoLC)38550070
040 $aUk$cUk$dMoU$dDLC
042 $alccopycat
050 00 $aRM405.5$b.S45 1998
082 00 $a615.7$221
245 00 $aSelective COX-2 inhibitors :$bpharmacology, clinical effects, and therapeutic potential : proceedings of a conference held on March 20-21, 1997, in Cannes, France /$cedited by Sir John Vane and Jack Botting.
260 $aDordrecht ;$aLondon :$bKluwer Academic,$cc1998.
300 $aix, 150 p. :$bill. ;$c24 cm.
500 $aThe conference was supported by an educational grant from Boehringer Ingelheim.
500 $aIncludes index.
650 0 $aCyclooxygenases$xInhibitors$vCongresses.
650 0 $aNonsteroidal anti-inflammatory agents$xCongresses.
650 12 $aCyclooxygenase Inhibitors$vcongresses.
650 22 $aAnti-Inflammatory Agents, Non-Steroidal$vcongresses.
700 1 $aVane, John R.
700 1 $aBotting, Jack H.
711 2 $aWilliam Harvey Research Conference$d(1997 :$cCannes, France)